|
Update - Wyeth gets final OTC Claritin approval.
Publication: Pharma Marketletter Publication Date: 06-JAN-03 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 Marketletter Publications Ltd.
US drugmaker Wyeth says that the US Food and Drug Administration has granted final approval to the company's application for Alavert (loratadine) a generic version of Schering-Plough's Claritin brand of the antihistamine which was approved for over-the-counter sale towards the end of last year (Marketletter December 2, 2002), the...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Pharma Marketletter |
SPECTRUM.
January 06, 2003
|
Stock Commentary - Europe - 2 weeks to Dec 30.
January 06, 2003
|
New York Stock Commentary - 2 weeks to Dec 30.
January 06, 2003
|
ICN turns up heat on Ribapharm board.
January 06, 2003
|
Forest Labs raises earnings estimate.
January 06, 2003
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
